Performing Cost-Effectiveness Analysis by Integrating Randomized Trial Data with a Comprehensive Decision Model
- 1 March 1999
- journal article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 52 (3), 259-271
- https://doi.org/10.1016/s0895-4356(98)00151-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Utilities for major stroke: Results from a survey of preferences among persons at increased risk for strokeAmerican Heart Journal, 1998
- The Stroke Prevention Policy Model: Linking Evidence and Clinical DecisionsAnnals of Internal Medicine, 1997
- Assessing Uncertainty in Cost-Effectiveness AnalysesMedical Decision Making, 1997
- Knowledge of Risk Among Patients at Increased Risk for StrokeStroke, 1997
- What Role Do Neurologists Play in Determining the Costs and Outcomes of Stroke Patients?Stroke, 1996
- The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of lifeArchives of Internal Medicine, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Patient preferences for stroke outcomes.Stroke, 1994
- The Stroke Prevention Patient Outcomes Research Team. Goals and methods.Stroke, 1993
- Cerebral Vascular Accidents in Patients over the Age of 60: II. PrognosisScottish Medical Journal, 1957